Hyperandrogenic women treated with a continuous-regimen oral contraceptive

Eur J Obstet Gynecol Reprod Biol. 2013 Dec;171(2):307-10. doi: 10.1016/j.ejogrb.2013.09.039. Epub 2013 Oct 10.

Abstract

Objectives: To investigate the effects of a continuous-regimen combined oral contraceptive (COC) on hyperandrogenic women.

Study design: This prospective study enrolled 52 women with moderate to severe hirsutism, as well as acne and seborrhea. Women were placed on a 192-day continuous regimen. To assess hirsutism, the modified Ferriman-Gallwey (mF-G) scoring system was used. Acne and seborrhea were defined by the Cremoncini scale. Serum FSH, LH, estradiol, total testosterone, FAI, DHEAS, androstenedione, SHBG and fasting insulin were measured at baseline and at the endpoint. One-way ANOVA was used to compare serum hormone levels and hirsutism scores at baseline with those obtained at the endpoint.

Results: A reduction of 78.5% in the mF-G scores was observed at the endpoint (p<0.001). Women underwent improvement of acne and seborrhea, -58.7% and -56%, respectively (p<0.001). An evident decrease in both total testosterone and FAI, and an increase in SHBG were shown (p<0.001).

Conclusions: A COC continuous-regimen improved the esthetic effect of hyperandrogenism.

Keywords: Acne; COC continuous regimen; Drospirenone; Hyperandrogenism; Seborrhea.

Publication types

  • Evaluation Study

MeSH terms

  • Acne Vulgaris / drug therapy
  • Adolescent
  • Androgens / blood
  • Androstenes / administration & dosage
  • Contraceptives, Oral, Combined / administration & dosage*
  • Dermatitis, Seborrheic / drug therapy
  • Ethinyl Estradiol / administration & dosage
  • Female
  • Hirsutism / drug therapy
  • Humans
  • Hyperandrogenism / drug therapy*
  • Prospective Studies
  • Sex Hormone-Binding Globulin / metabolism
  • Testosterone / blood

Substances

  • Androgens
  • Androstenes
  • Contraceptives, Oral, Combined
  • Sex Hormone-Binding Globulin
  • Testosterone
  • Ethinyl Estradiol
  • drospirenone